| pubmed-article:10757572 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10757572 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:10757572 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:10757572 | lifeskim:mentions | umls-concept:C0018801 | lld:lifeskim |
| pubmed-article:10757572 | lifeskim:mentions | umls-concept:C0128513 | lld:lifeskim |
| pubmed-article:10757572 | lifeskim:mentions | umls-concept:C0010340 | lld:lifeskim |
| pubmed-article:10757572 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:10757572 | pubmed:dateCreated | 2000-6-5 | lld:pubmed |
| pubmed-article:10757572 | pubmed:abstractText | Treatment with the PDE-III inhibitor milrinone improves hemodynamics in patients with heart failure. We examined whether therapy with milrinone is safe and effective in critically ill patients with catecholamine-dependent heart failure and whether treatment with milrinone facilitates weaning from prolonged catecholamine therapy. | lld:pubmed |
| pubmed-article:10757572 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10757572 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10757572 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10757572 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10757572 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10757572 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10757572 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10757572 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10757572 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10757572 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10757572 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:10757572 | pubmed:issn | 0001-5172 | lld:pubmed |
| pubmed-article:10757572 | pubmed:author | pubmed-author:HeinzGG | lld:pubmed |
| pubmed-article:10757572 | pubmed:author | pubmed-author:HaumerMM | lld:pubmed |
| pubmed-article:10757572 | pubmed:author | pubmed-author:SiostrzonekPP | lld:pubmed |
| pubmed-article:10757572 | pubmed:author | pubmed-author:Koller-Strame... | lld:pubmed |
| pubmed-article:10757572 | pubmed:author | pubmed-author:Delle-KarthGG | lld:pubmed |
| pubmed-article:10757572 | pubmed:author | pubmed-author:KorenyMM | lld:pubmed |
| pubmed-article:10757572 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10757572 | pubmed:volume | 44 | lld:pubmed |
| pubmed-article:10757572 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10757572 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10757572 | pubmed:pagination | 403-9 | lld:pubmed |
| pubmed-article:10757572 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:10757572 | pubmed:meshHeading | pubmed-meshheading:10757572... | lld:pubmed |
| pubmed-article:10757572 | pubmed:meshHeading | pubmed-meshheading:10757572... | lld:pubmed |
| pubmed-article:10757572 | pubmed:meshHeading | pubmed-meshheading:10757572... | lld:pubmed |
| pubmed-article:10757572 | pubmed:meshHeading | pubmed-meshheading:10757572... | lld:pubmed |
| pubmed-article:10757572 | pubmed:meshHeading | pubmed-meshheading:10757572... | lld:pubmed |
| pubmed-article:10757572 | pubmed:meshHeading | pubmed-meshheading:10757572... | lld:pubmed |
| pubmed-article:10757572 | pubmed:meshHeading | pubmed-meshheading:10757572... | lld:pubmed |
| pubmed-article:10757572 | pubmed:meshHeading | pubmed-meshheading:10757572... | lld:pubmed |
| pubmed-article:10757572 | pubmed:meshHeading | pubmed-meshheading:10757572... | lld:pubmed |
| pubmed-article:10757572 | pubmed:meshHeading | pubmed-meshheading:10757572... | lld:pubmed |
| pubmed-article:10757572 | pubmed:meshHeading | pubmed-meshheading:10757572... | lld:pubmed |
| pubmed-article:10757572 | pubmed:meshHeading | pubmed-meshheading:10757572... | lld:pubmed |
| pubmed-article:10757572 | pubmed:meshHeading | pubmed-meshheading:10757572... | lld:pubmed |
| pubmed-article:10757572 | pubmed:meshHeading | pubmed-meshheading:10757572... | lld:pubmed |
| pubmed-article:10757572 | pubmed:meshHeading | pubmed-meshheading:10757572... | lld:pubmed |
| pubmed-article:10757572 | pubmed:meshHeading | pubmed-meshheading:10757572... | lld:pubmed |
| pubmed-article:10757572 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:10757572 | pubmed:articleTitle | Milrinone therapy in catecholamine-dependent critically ill patients with heart failure. | lld:pubmed |
| pubmed-article:10757572 | pubmed:affiliation | Department of Cardiology, University Clinic of Vienna, Austria. | lld:pubmed |
| pubmed-article:10757572 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10757572 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:10757572 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10757572 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10757572 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10757572 | lld:pubmed |
